home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410o.zip
/
M94A2874.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
3KB
|
41 lines
Document 2874
DOCN M94A2874
TI Nimodipine+ZDV vs ZDV in patients with ADC.
DT 9412
AU Galgani S; Narciso P; Balestra P; Pigorini F; Pau F; Sette P; Tozzi V;
Alba L; Grisetti S; Visco G; USLRM10, Rome, Italy.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):205 (abstract no. PB0248). Unique
Identifier : AIDSLINE ICA10/94369701
AB OBJECTIVE. To evaluate the activity of ZDV+Nimodipine (NMP) (an oral
calcium-channel blocking agent that may reduce HIV-induced neurotoxicity
in vitro) association in the treatment of HIV-induced cognitive
dysfunctions. METHODS. Design: open, case control study. Eligibility
criteria:CD4 cells < 500/mmc, ADC staging 0, 0.5, 1.2 (Price criteria).
Treatment regimens: NMP 90 mg/qd+ZDV 250 mg/bid vs ZDV 250 mg/bid.
Follow-up: laboratory controls every month, neurological examination
every 3 months, neuropsychological evaluations exploring attention,
memory, reasoning every 6 months, 99-mtc-HM-PAO SPECT exam every 6
months. Criteria for response: modification of ADC staging,
neuropsychological testing and SPECT findings. RESULTS. Details of
patients at enrollment: TABULAR DATA, SEE ABSTRACT VOLUME. Mean
follow-up was 6 months. After 6 months of treatment pts treated with
NMP+ZDV showed significantly better neuropsychological performances than
pts treated with ZDV alone (Wisconsin CSt for categories p = 0.01,
Wisconsin CSt for perseverative errors p = 0.02, Digit Symbol p = 0.03,
by ANOVA). No significative difference were seen in SPECT findings
although pts of the NMP+ZDV group showed a trend toward a development of
less pronounced up-take deficits. CONCLUSIONS. Pts treated with ZDV+NMP
show a trend to a better stability over time of neuropsychological
performance. This phenomenon was mainly observed in test exploring
frontal lobe functions.
DE Acquired Immunodeficiency Syndrome/*DRUG THERAPY/PSYCHOLOGY AIDS
Dementia Complex/*PREVENTION & CONTROL Case-Control Studies
Comparative Study Drug Evaluation Drug Therapy, Combination Human
Neuropsychological Tests Nimodipine/ADMINISTRATION &
DOSAGE/*THERAPEUTIC USE Treatment Outcome Zidovudine/ADMINISTRATION &
DOSAGE/*THERAPEUTIC USE MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).